The role of FDG PET/CT in patients with colorectal cancer metastases

Cancer Biomarkers

Volumn 7, Issue 4-5, 2010, Pages 235-248

  Kochhar, Rohit ^a   Liong, Sue ^a   Manoharan, Prakash ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

colorectal cancer; computed tomography; Positron emission tomography; recurrence; staging and hepatic metastases

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; COLORECTAL CANCER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79955612128     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0201     Document Type: Article

References (27)

1. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet and P. Boyle, Estimates of the cancer incidence and mortality in Europe in 2006, Ann Oncol 18 (2007), 581-592. (Pubitemid 46359643)
2. A. Verdecchia, S. Francisci, H. Brenner, G. Gatta, A. Micheli, L. Mangone, L. Kunkler and EUROCARE-4 Working group, Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data, Lancet Oncol 8 (2007), 784-796. (Pubitemid 47321601)
3. A.G. Renehan, S.T. O'Dwyer and D.K. Whynes, Cost effec-tiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer, BMJ 328 (2004), 81.
4. L.H. Jensen, R. Altaf, H. Harling, M. Jensen, S. Laurberg, J.C. Lindegaard, A. Muhic, L. Vestermark, A. Jakobsen, S. Bülow and Danish Colorectal Cancer Group, Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy, EurJSurg Oncol 36 (2010), 237-243.
5. T.M. Pawlik and M.A. Choti, Surgical therapy for colorectal metastases to the liver, J Gastrointest Surg 11 (2007), 1057-1077.
6. R.A. Herbertson, A.F. Scarsbrook, S.T. Lee, N. Tebbutt and A.M. Scott, Established, emerging and future roles of PET/CT inthemanagement ofcolorectal cancer, ClinRadiol64(2009), 225-237.
7. J.W. Fletcher, B. Djulbegovic, H.P. Soares, B.A. Siegel, V.J. Lowe, G.H. Lyman, R.E. Coleman, R. Wahl, J.C. Paschold, N. Avril, L.H. Einhorn, W.W. Suh, D. Samson, D. Delbeke, M. Gorman and A.F. Shields, Recommendations onthe use of 18F-FDG PET in oncology, J Nucl Med 49 (2008), 480-508. (Pubitemid 351355215)
8. B. Wiering, PF. Krabbe, G.J. Jager, W.J. Oyen and T.J. Ruers, The impact of fluoro-18-deoxyglucose-positron emission to-mography in the management of colorectal liver metastases, Cancer 104 (2005), 2658-2670. (Pubitemid 41798276)
9. A.M. Scott, D.H. Gunawardana, B. Kelley, J.G. Stuckey, A.J. Byrne, J.E. Ramshaw and M. J. Fulham, PET changes manage-ment and improves prognostic stratification in patients with re-current colorectal cancer: results of a multicenter prospective study J Nucl Med 49 (2008), 1451-1457.
10. V. Kalff, R.J. Hicks, R.E. Ware, A. Hogg, D. Binns and A.F. McKenzie, The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: aprospective study, J Nucl Med 43 (2002), 492-499. (Pubitemid 34286344)
11. J. Meta, M. Seltzer, C Schiepers, D.H. Silverman, M. Ari-annejad, S.S. Gambhir, M.E. Phelps, P. Valk and J. Czernin, Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective, J Nucl Med 42 (2001), 586-590. (Pubitemid 32298278)
12. G. Kong, C Jackson, D.M. Koh, V. Lewington, B. Sharma, G. Brown, D. Cunningham and G.J. Cook, The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI, Eur J Nucl Med Mol Imaging 35 (2008), 1323-1329.
13. V.P. Khatri, K.G. Chee andN.J. Petrelli, Modern multimodal-ity approach to hepatic colorectal metastases: solutions and controversies, Surg Oncol 16 (2007), 71-83. (Pubitemid 46880341)
14. F.G. Fernandez, J.A. Drebin, D.C. Linehan, F. Dehdashti, B.A. Siegel and S.M. Strasberg, Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglu-cose (FDG-PET), Ann Surg 240 (2004), 438-450. (Pubitemid 39121338)
15. S. Bipat, M.S. van Leeuwen, E.F. Comans, M.E. Pijl, P.M. Bossuyt, A.H. Zwinderman and J. Stoker, Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis, Radiology 237 (2005), 123-131. (Pubitemid 41346155)
16. E. Squillaci, G. Manenti, S. Mancino, C Ciccio, F. Calabria, R. Danieli, O. Schillaci and G. Simonetti, Staging of colon cancer: whole-body MRI vs. whole-body PET-CT-initial clin-ical experience, Abdom Imaging 33 (2008), 676-688.
17. R. Hammerstingl, A. Huppertz, J. Breuer, T Balzer, A. Blake-borough, R. Carter, L.C. Fusté, G. Heinz-Peer, W. Judmaier, M. Laniado, R.M. Manfredi, D.G. Mathieu, D. Müller, K. Mortelè, P. Reimer, M.F. Reiser, PJ. Robinson, K. Shamsi, M. Strotzer, M. Taupitz, B. Tombach, G. Valeri, B.E. van Beers, TJ. Vogl and European EOB-study group, Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions, Eur Radiol 18 (2008), 457-467. (Pubitemid 351248177)
18. U. Landes, J. Robert, T Perneger, G. Mentha, V Ott, P. Morel and P. Gervaz, Predicting survival after pulmonary metastasec-tomy for colorectal cancer: previous liver metastases matter, BMC Surg 10 (2010), 17.
19. T Treasure, L. Fallowfield and B. Lees, Pulmonary metas-tasectomy in colorectal cancer: the PulMiCC trial, J Thorac Oncol 5 (2010), S203-S206.
20. E. Belcher, A.G. Nicholson, D.M. Hansell and P. Goldstraw, Imaging characteristics of a mucinous colorectal pulmonary metastasis, Ann Thorac Surg 86 (2008), 1698.
21. K.L. Berger, S.A. Nicholson, F. Dehdashti and B.A. Siegel, FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features, Am J Roentgenol 174 (2000), 1005-1008. (Pubitemid 30179992)
22. N. Lubezky, U. Metser, R. Geva, R. Nakache, E. Shmueli, J.M. Klausner, E. Even-Sapir, A. Figer and M. Ben-Haim, The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized to-mography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings, J Gastrointest Surg 11 (2007), 472-478.
23. C Lejeune, M.J. Bismuth, T Conroy, C Zanni, P. Bey, L. Be-denne, J. Faivre, P. Arveux and F. Guillemin, Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer, Nucl Med 46 (2005), 2020-2028. (Pubitemid 46657449)
24. J.M. Zubeldia, E.M. Bednarczyk, J.G. Baker and H.A. Nabi, The economic impact of 18FDG positron emission tomog-raphy in the surgical management of colorectal cancer with hepatic metastases, Cancer Biother Radiopharm 20 (2005), 450-456. (Pubitemid 41216109)
25. M.M. D'Souza, R. Sharma, A. Mondal, A. Jaimini, M. Tri-pathi, S.K. Saw, D. Singh, A. Mishra and R.P. Tripathi, Prospective evaluation of CECT and 18F-FDG-PET/CT in de-tection of hepatic metastases, Nucl Med Commun 30 (2009), 117-125.
26. K. Kitajima, K. Murakami, E. Yamasaki, Y. Domeki, Y. Kaji, S. Morita, N. Suganuma and K. Sugimura, Performance of in-tegrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT, Eur J Nucl Med Mol Imaging 36 (2009), 362-372.
27. J.D. Soyka, P. Veit-Haibach, K. Strobel, S. Breitenstein, A. Tschopp, K.A. Mende, M.P. Lago and T.F. Hany, Stagingpath-ways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDGPET/CTthe diagnostic tool of choice? J Nucl Med 49 (2008), 354-361. (Pubitemid 351355199)